Late-onset cytomegalovirus reactivation in critically ill renal transplant patients. Jochimsen, F., Westhoff, T., Engelmann, E., Schafer, J., Offermann, G., & Zidek, W. Transplantation, 76(2):430--432, July, 2003.
doi  abstract   bibtex   
BACKGROUND: Cytomegalovirus (CMV) reactivation occurs frequently in the first months after renal transplantation. However, reports concerning long-term kidney transplant recipients are rare and have always pertained to symptomatic CMV disease. METHODS: We report four cases of late-onset asymptomatic CMV reactivation in critically ill renal transplant patients who suffered from severe bacterial infections and in whom CMV antigenemia was observed. RESULTS AND CONCLUSION: CMV reactivation in these patients might indicate an additional disturbance in the patients' immune defenses at the time of critical illness, possibly even necessitating a temporary reduction in immunosuppressive therapy. Prospective, controlled trials are needed to define the role of CMV antigenemia in critically ill patients, including the role of antiviral therapy for asymptomatic reactivations.
@article{jochimsen_late-onset_2003,
	title = {Late-onset cytomegalovirus reactivation in critically ill renal transplant patients.},
	volume = {76},
	issn = {0041-1337 0041-1337},
	doi = {10.1097/01.TP.0000075091.80548.5B},
	abstract = {BACKGROUND: Cytomegalovirus (CMV) reactivation occurs frequently in the first months after renal transplantation. However, reports concerning long-term kidney  transplant recipients are rare and have always pertained to symptomatic CMV disease. METHODS: We report four cases of late-onset asymptomatic CMV reactivation in critically ill renal transplant patients who suffered from severe bacterial infections and in whom CMV antigenemia was observed. RESULTS AND CONCLUSION: CMV reactivation in these patients might indicate an additional disturbance in the patients' immune defenses at the time of critical illness, possibly even necessitating a temporary reduction in immunosuppressive therapy. Prospective, controlled trials are needed to define the role of CMV antigenemia in critically ill patients, including the role of antiviral therapy for asymptomatic reactivations.},
	language = {eng},
	number = {2},
	journal = {Transplantation},
	author = {Jochimsen, Friederike and Westhoff, Timm and Engelmann, Elisabeth and Schafer, Jurgen-Heiner and Offermann, Gerd and Zidek, Walter},
	month = jul,
	year = {2003},
	pmid = {12883206},
	keywords = {*Kidney Transplantation, Acute Disease, Aged, Antiviral Agents/administration \& dosage, Bacterial Infections/*complications, Critical Illness, Cytomegalovirus Infections/*complications/drug therapy, Female, Ganciclovir/administration \& dosage, Humans, Middle Aged, Neutrophils/virology, Phosphoproteins/analysis, Recurrence, Superinfection/complications, Time Factors, Viral Matrix Proteins/analysis},
	pages = {430--432}
}

Downloads: 0